Hydrochloric Acid → N4-(9-azaspiro[5.5]undecan-3-yl)-5-chloro-N2-(2,3-dimethylindazol-6-yl)pyrimidine-2,4-diamine
Reaction equation
[Cl:1][C:2]1[C:3]([NH:20][CH:21]2[CH2:38][CH2:37][C:24]3([CH2:29][CH2:28][N:27](C(OC(C)(C)C)=O)[CH2:26][CH2:25]3)[CH2:23][CH2:22]2)=[N:4][C:5]([NH:8][C:9]2[CH:10]=[CH:11][C:12]3[C:16]([CH:17]=2)=[N:15][N:14]([CH3:18])[C:13]=3[CH3:19])=[N:6][CH:7]=1.Cl.CCOC(C)=O>C(Cl)Cl>[Cl:1][C:2]1[C:3]([NH:20][CH:21]2[CH2:22][CH2:23][C:24]3([CH2:25][CH2:26][NH:27][CH2:28][CH2:29]3)[CH2:37][CH2:38]2)=[N:4][C:5]([NH:8][C:9]2[CH:10]=[CH:11][C:12]3[C:16]([CH:17]=2)=[N:15][N:14]([CH3:18])[C:13]=3[CH3:19])=[N:6][CH:7]=1Participants
5
Procedure
To a solution of tert-butyl 9-((5-chloro-2-((2,3-dimethyl-2H-indazol-6-yl)amino)pyrimidin-4-yl)amino)-3-azaspiro[5.5]undecane-3-carboxylate (161.5 mg, 0.30 mmol) in DCM (10 mL) was added a solution of HCl in EtOAc (10 mL, 40 mmol). The reaction mixture was stirred at rt for 2 h and concentrated in vacuo. The residue was dissolved in water (30 mL) and adjusted to pH=10 with a saturated Na2CO3 aqueous solution, then extracted with DCM (100 mL×3). The combined organic phases were washed with brine (100 mL), dried over anhydrous Na2SO4, concentrated in vacuo. The residue was purified by silica gel column chromatography (MeOH/DCM (v/v)=1/10) to give the title compound as a beige solid (131.6 mg, 100%).
Workup
- concentrationconcentrated in vacuo
- dissolutionThe residue was dissolved in water (30 mL)
- extractionextracted with DCM (100 mL×3)
- washThe combined organic phases were washed with brine (100 mL)
- dry with materialdried over anhydrous Na2SO4
- concentrationconcentrated in vacuo
- customThe residue was purified by silica gel column chromatography (MeOH/DCM (v/v)=1/10)
Sources & evidence
- ORD record
- ord-94898bc1682d4c1ca486e6aa1b6e0946
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09399637B2
Reaction notes
Loading…